What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to officially announce Gilead Sciences' financial results for the third quarter ended September 30, 2007, by attaching the press release that contains these results.

What is 'non-GAAP' financial information, and why does Gilead present it?

Non-GAAP financial information is an alternative measure of financial performance that excludes certain items that management believes are not indicative of ongoing operational performance. Gilead presents non-GAAP figures to exclude stock-based compensation expense (and other specific items for prior periods) because management believes it offers a more useful perspective for investors on the company's operating results, budgeting, and financial planning.

Are the specific financial numbers (revenue, profit, EPS) included in the 8-K document itself?

No, the 8-K document itself does not contain the detailed financial figures. Instead, it references and includes a press release (Exhibit 99.1) which contains the full financial results for the quarter.

What specific items are excluded from Gilead's non-GAAP reporting for the third quarter of 2007?

For the third quarter of 2007, Gilead's non-GAAP reporting excludes the impact of stock-based compensation expense and the related methodology for deriving dilutive securities.

GILD 8-K: Earnings & Results

Summary

Gilead Sciences, Inc. (GILD) filed a Current Report (8-K) on October 18, 2007, to announce its financial results for the third quarter ended September 30, 2007. The report includes a press release detailing these results, which are presented on both a GAAP and a non-GAAP basis. The company emphasizes that its non-GAAP reporting excludes stock-based compensation expenses and other specific items to provide what management believes is a more useful view for investors regarding operational performance, budgeting, and financial planning. Investors should note that the press release itself contains the substantive financial information. The 8-K filing serves as the mechanism to submit this information to the SEC. While the specific figures are within the attached press release (Exhibit 99.1), the 8-K itself confirms the timing and purpose of the announcement. Management's belief that non-GAAP measures offer enhanced insight is a key point for understanding how the company frames its performance.

Key Highlights

1Gilead Sciences announced its third quarter 2007 financial results on October 18, 2007, via an 8-K filing.
2The filing includes a press release (Exhibit 99.1) containing the detailed financial results for the quarter ended September 30, 2007.
3Gilead presented its financial results on both Generally Accepted Accounting Principles (GAAP) and non-GAAP bases.
4Non-GAAP figures exclude stock-based compensation expense and related methodology for dilutive securities.
5For 2006 non-GAAP figures, additional exclusions include the impact of purchased in-process R&D from the Corus Pharma, Inc. acquisition.
6Management believes non-GAAP measures provide a more useful view for investors concerning operating performance, budgeting, and financial planning.
7The company cautioned that non-GAAP information should supplement, not replace, the understanding of results under GAAP.

GILEAD SCIENCES, INC. 8-K Report, Financial Results (Oct 18, 2007)

Summary

Key Highlights

Frequently Asked Questions